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Abstract
Objective To investigate whether an early rehabilitation intervention
initiated during acute admission for exacerbations of chronic respiratory
disease reduces the risk of readmission over 12 months and ameliorates
the negative effects of the episode on physical performance and health
status.
Design Prospective, randomised controlled trial.
Setting An acute cardiorespiratory unit in a teaching hospital and an
acute medical unit in an affiliated teaching district general hospital, United
Kingdom.
Participants 389 patients aged between 45 and 93 who within 48 hours
of admission to hospital with an exacerbation of chronic respiratory
disease were randomised to an early rehabilitation intervention (n=196)
or to usual care (n=193).
Main outcome measures The primary outcome was readmission rate
at 12 months. Secondary outcomes included number of hospital days,
mortality, physical performance, and health status. The primary analysis
was by intention to treat, with prespecified per protocol analysis as a
secondary outcome.
Interventions Participants in the early rehabilitation group received a
six week intervention, started within 48 hours of admission. The
intervention comprised prescribed, progressive aerobic, resistance, and
neuromuscular electrical stimulation training. Patients also received a
self management and education package.
Results Of the 389 participants, 320 (82%) had a primary diagnosis of
chronic obstructive pulmonary disease. 233 (60%) were readmitted at
least once in the following year (62% in the intervention group and 58%
in the control group). No significant difference between groups was found
(hazard ratio 1.1, 95% confidence interval 0.86 to 1.43, P=0.4). An
increase in mortality was seen in the intervention group at one year
(odds ratio 1.74, 95% confidence interval 1.05 to 2.88, P=0.03).
Significant recovery in physical performance and health status was seen
after discharge in both groups, with no significant difference between
groups at one year.
Conclusion Early rehabilitation during hospital admission for chronic
respiratory disease did not reduce the risk of subsequent readmission
or enhance recovery of physical function following the event over 12
months. Mortality at 12 months was higher in the intervention group.
The results suggest that beyond current standard physiotherapy practice,
progressive exercise rehabilitation should not be started during the early
stages of the acute illness.
Trial registration Current Controlled Trials ISRCTN05557928.
Correspondence to: N J Greening njg27@le.ac.uk
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Introduction
Patients admitted to hospital with acute exacerbations of chronic
obstructive pulmonary disease and other chronic respiratory
diseases, such as chronic asthma, bronchiectasis, and interstitial
lung disease, are at increased risk of mortality, morbidity, and
further episodes of unscheduled hospital admission. Acute
exacerbation of chronic obstructive pulmonary disease is the
secondmost common cause for unscheduled hospital admission
in the United Kingdom, accounting for the largest component
of health costs associated with the disease.1
Admission to hospital has negative effects on physical
performance and health status from which the patient may not
fully recover.2 3 Treatment of the acute episode is predominantly
targeted at improvement of ventilatory function, with little
attention paid to these wider systemic impacts. Consequently,
physical performance and activity may be reduced for a
prolonged period after hospital stay, increasing the risk of
readmission.2 4 5
Pulmonary rehabilitation is of established efficacy in stable
chronic respiratory diseases, and small scale trials of pulmonary
rehabilitation delivered after discharge from hospital for chronic
obstructive pulmonary disease have suggested a reduction in
the short term risk of readmission. However, the effects of the
acute episode on physical fitness and skeletal muscle function
may occur rapidly during the inpatient phase4 6 suggesting that
a rehabilitation intervention delivered at the time of the acute
illness might preserve physical function and reduce the risk of
subsequent admission to hospital. This is supported by previous
small scale trials of exercise based therapy during acute
exacerbation of chronic obstructive pulmonary disease, which
have suggested such interventions are feasible and may be
effective.7-9 An early exercise/mobility intervention is a
component of wider enhanced recovery programmes, which
have been successfully implemented for patients undergoing
elective surgery but have not beenwidely applied to unscheduled
medical admissions.10-12
We conducted a randomised clinical trial of a progressive,
exercise based rehabilitation intervention delivered immediately
after unscheduled admission to hospital for an acute exacerbation
of chronic respiratory disease. The principles underpinning the
intervention were that it should be delivered early in the
admission with the aim of preventing decline in physical
performance, should be provided intensively making best use
of the time spent in hospital, and should be continued after
discharge to maximise the restoration of physical performance
and activity and obviate the need to extend the hospital stay to
provide treatment.We hypothesised that this intervention would
reduce the risk of readmission in the following year and
accelerate recovery of physical functioning.
Methods
Study design
This was a prospective, parallel group, single blind randomised
controlled trial conducted in two centres in the United Kingdom:
an acute cardiorespiratory unit in a teaching hospital (Glenfield
Hospital, University Hospitals of Leicester) and an acutemedical
unit in an affiliated teaching district general hospital (Kettering
General Hospital).
We randomly allocated patients to one of two treatment groups:
an early rehabilitation group and a usual care group. Participants
randomised to the early rehabilitation group received a six week
intervention.
Outcomes were measured at baseline, discharge from hospital,
six weeks from randomisation, three months, and 12 months.
The nature of the intervention meant that blinding of the
participants was not possible, but all investigators performing
the outcome measures were blinded to treatment allocation.
Study population
Participants were recruited to the study and randomised within
48 hours of admission to hospital with an exacerbation of
chronic respiratory disease. Inclusion criteria were diagnosis of
chronic respiratory disease (chronic obstructive pulmonary
disease, chronic asthma, bronchiectasis, or interstitial lung
disease), self reported breathlessness on exertion when stable
(Medical Research Council dyspnoea grade 3 or worse), and
age 40 years or greater. Exclusion criteria were inability to
provide informed consent; concomitant acute cardiac event;
presence of musculoskeletal, neurological, or psychiatric
comorbidities that would prevent the delivery of the
rehabilitation intervention; and more than four emergency
admissions to hospital for any cause in the previous 12 months.
Usual care group
Participants assigned to the usual care group received standard
care from the ward clinical physiotherapy team as directed by
the responsible clinical team. This included physiotherapist
delivered techniques for airway clearance, assessment and
supervision of mobility, and advice on smoking cessation.
Nutritional status was assessed using the malnutrition universal
screening tool score in all participants, and referral for dietetic
advice and nutritional support was carried out if appropriate.
No supervised or progressive exercise programmewas provided
during the admission or immediately after discharge, but
outpatient pulmonary rehabilitation was offered to all
participants three months after discharge as part of standard
care.
Early rehabilitation group
Participants allocated to the intervention group started early
rehabilitation within 48 hours of hospital admission. In addition
to usual care, they also received daily, supervised volitional
(strength and aerobic training) and non-volitional
(neuromuscular electrical stimulation) techniques. The
pulmonary rehabilitation team, consisting of physiotherapists
and nurses, delivered the early rehabilitation programme. The
exercise programmewas individually prescribed and progressed
(fig 1⇓). Early rehabilitation was performed on the acute medical
ward and by the participants’ bedside. After discharge,
participants underwent an unsupervised home based programme,
supported by telephone consultations. Those who were
readmitted after the six week intervention period did not receive
a further early rehabilitation intervention.
Aerobic training
Daily walking was performed at a set walking speed
predetermined by the endurance shuttle walk test at 85% oxygen
consumption (VO2) max (calculated from the incremental shuttle
walk test). If participants were not able to walk 10 m in 20
seconds (1.78 km/h) then they performed daily timed walks at
a manageable speed. Walking time was progressed at the
prescribed walking speed, maintaining a Borg breathlessness
score of between 3 and 5 (from 0 for no breathlessness to 10
for the most severe breathlessness) and a Borg exertion score
for rating perceived exertion <13 (from 6 for no exertion at all
to 20 for maximal exertion).
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Strength training
Patients completed daily strength training, comprising three sets
of eight repetitions resistance training exercises with weights.
This was performed for biceps curls, triceps curls, knee
extension, sit to stand, and step-ups, which was based on the
one repetition maximum. Once the rate of perceived exertion
was <13 the weight was increased.
Non-volitional training
The intervention team initially supervised the neuromuscular
electrical stimulation until participants were deemed able to use
independently. Neuromuscular electrical stimulation (Empi
300PV,MN) was applied to both quadriceps synchronously for
30 minutes daily. The stimulation protocol consisted of a
symmetrical biphasic pulse at 50 Hz, pulse duration of 300 ms,
15 seconds on and five seconds off. The intensity was increased
by the therapist or patient according to tolerance. Neuromuscular
electrical stimulation continued throughout both the inpatient
and the outpatient intervention period.
Supported self management programme
The intervention team delivered education using the SPACE
(Self management programme of Activity, Coping and
Education) manual for chronic obstructive pulmonary disease,
a structured programme of exercise, education, and psychosocial
support. Motivational interviewing techniques were used to
introduce patients to the manual and to familiarise them with
the content. The manual was used throughout the participants’
inpatient stay and in the subsequent discussions during telephone
calls.
Post-discharge training
After discharge we advised the participants to follow a
progressive walking based home exercise programme and to
continue daily neuromuscular electrical stimulation, and we
encouraged them to follow the self management programme.
The post-discharge training was supported by telephone
consultations from the pulmonary rehabilitation intervention
team, using motivational interviewing techniques, at 48 hours,
two weeks, and four weeks. Participants were encouraged with
adherence and progression of their exercise programme.
Participants were also able to discuss any concerns that they
may have and were given advice on ongoing management of
their condition.
Primary and secondary outcomes
The primary endpoint was unplanned readmissions to hospital
at 12 months for all causes, adjusted for site. We captured
hospital admissions in the follow-up period using hospital
databases and general practice records. Secondary analyses of
healthcare utilisation included per protocol analysis (defined as
retention within the trial during the six week intervention
period), time to first readmission, total days spent in hospital,
cause of admission (respiratory or non-respiratory), and
mortality (including cause of death and time from primary
admission). Secondary functional outcome measures were
recorded at baseline (where feasible), discharge from hospital,
six weeks, and three and 12months. At baseline, the acute illness
prevented the recording of physiological and exercise
performance measures other than quadriceps strength.
Spirometry was measured to British Thoracic Society
standards.13 Exercise performance was measured using the
incremental shuttle walk test14 and endurance shuttle walk test.15
Maximal isometric quadriceps strength was measured using an
isometric dynamometer.16 Disease specific health status was
measured using the St George’s respiratory questionnaire.17
Statistical analysis
The clinical trials unit at the University of Leicester coordinated
randomisation by an automated internet based service (www.
sealedenvelope.com). Participants were randomly allocated in
a simple 1:1 ratio.
We used an intention to treat analysis to assess the primary
outcome. The study was powered to detect a difference in
readmission rate of 15% (usual care 40%, early rehabilitation
25%), requiring 152 in each group (power 80%, two sided
α=0.05). With the expected mortality (20%) we planned to
recruit 190 participants to each group (380 in total). Analyses
were performed using STATA version 13. We compared
baseline measures using the t test for parametric data,
Mann-Whitney U test for non-parametric data, and χ2 tests for
categorical data. The rate of admission to hospital was calculated
using a Fine-Gray competing risks analysis, with death as the
competing risk (adjusted for site), presented as hazard ratios.18
We used negative binomial regression (offset by natural log of
time to death) to calculate secondary outcomes of differences
in number of hospital admissions and hospital days, presented
as incident rate ratios. Binary logistic regression was used to
calculate mortality odds ratios. Hazard and odds ratios are
presented in comparison with the usual care group. Secondary
healthcare utilisation measures are presented both unadjusted
(other than for site) and adjusted for covariables known to affect
the risk of hospital admission (site, age, diagnosis, Medical
Research Council grade for dyspnoea, previous hospital stays,
quadriceps strength at baseline, number of comorbidities). For
the utilisation of healthcare we conducted a predefined per
protocol analysis, defined as those who remained in the study
during the intervention period.We analysed longitudinal changes
in physiological outcomes using repeated measures analysis of
variance (corrected for site). Bonferroni correction was applied
for analyses at six weeks and three months.
We used multiple imputation by chained equations to replace
missing data for the functional measures (incremental shuttle
walk test, endurance shuttle walk test, maximal isometric
quadriceps strength, St George’s respiratory questionnaire).
Forty imputed datasets were created (see supplementary
appendix).
Results
Recruitment and baseline characteristics
Overall, 389 participants were recruited between January 2010
and September 2011, with final follow-up in September 2012:
196 were randomised to early rehabilitation and 193 to usual
care. Recruitment was similar at both sites (Glenfield n=200,
Kettering n=189). Figure 2⇓ shows the flow of screening,
randomisation, and follow-up in the study. No statistically
significant differences for personal characteristics and measures
were observed between the intervention and usual care groups
at baseline (table 1⇓). The forced expiratory volume in one
second recorded in the stable state before the index admission
(available in 136 (69%) and 131 (68%) of the intervention and
usual care groups, respectively) was significantly lower in the
intervention group, although spirometry recorded at discharge
did not differ significantly between the groups (n=332, P=0.1).
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Index admission
The median length of hospital stay during the index admission
was five days (range 1-33 days) for the intervention group and
five days (range 1-31 days) for the usual care groups (P=0.9).
On admission, 338 (87%) participants received systemic
corticosteroids and 317 (82%) received antibiotics, with no
significant differences between the groups (P=0.5 and P=0.6).
Overall, 271 (70%) participants received supplemental oxygen
on admission (no difference between groups, P=0.4). Eleven
(3%) deaths occurred during the index admission (six (3%) in
the usual care group and five (3%) in the early rehabilitation
group, P=0.3), of whom eight of the 11 (73%) had withdrawn
from the trial before death.
Adherence to early rehabilitation training
A total of 165 (86%) participants performed inpatient aerobic
training, 176 (90%) inpatient resistance training, and 176 (90%)
inpatient neuromuscular electrical stimulation training. The
mean number of sessions during the inpatient training was 2.7
(SD 2.6) for aerobic training, 2.5 (SD 1.9) for resistance training,
and 3.6 (SD 3.2) for neuromuscular electrical stimulation
training. This was associated with increases in exercise training
walk times (76 s, 95% confidence interval 56 to 96 s, P<0.001),
intensity of neuromuscular electrical stimulation training (4
mA, 95% confidence interval 3 to 5 mA, P<0.001), and weight
used in resistance training (100 g, 95% confidence interval 60
to 140 g, P<0.001).
After discharge further improvements were reported in walking
time (304 s, 95% confidence interval 152 to 457 s, P<0.001)
but the change in progression of resistance training was not
significant. At the end of the intervention period, continued
daily adherence to the home programme was reported by 54%
of participants for aerobic training and 61% for resistance
training.
Hospital readmissions
During the follow-up period, 233 (60%) participants were
readmitted, with 599 admissions. A respiratory cause accounted
for 447 (75%) of these readmissions. The difference in the
number of participants with at least one readmission was not
significant; usual care 111/193 (58%), early rehabilitation
122/196 (62%): hazard ratio 1.1 (95% confidence interval 0.86
to 1.43), P=0.4. Figure 3⇓ shows the risk of readmission over
time. For each patient there was amean of 1.54 (95% confidence
interval 1.33 to 1.75) hospital admissions in the year after the
index admission, with no difference between groups (P=0.9).
Table 2⇓ presents the data for admissions for respiratory and
non-respiratory causes. The median time to the first hospital
admission did not differ significantly (89 days for usual care
and 93.5 days for early rehabilitation, P=0.4).
Mortality
Eighty deaths (21%) occurred in the study population during
the follow-up period, 23 (29%) occurring without readmission
(usual care n=11 (35%), early rehabilitation n=12 (24%)).
Unadjusted and adjusted mortality rates were higher in the
intervention group at 12 months (31 (16%) in the usual care
group and 49 (25%) in the early rehabilitation group, odds ratio
1.74, 95% confidence interval 1.05 to 2.88, P=0.03, fig 4⇓). See
supplementary table S2 for causes of death.
Number of hospital days
During the follow-up period the number of hospital days was
5211 (usual care 2861 and early rehabilitation 2350 days, table
2). The total number of days spent in hospital was similar in the
two groups (difference 18%, z=−0.5, P=0.6).
Per protocol analysis
Sixty one (16%) participants withdrew during the intervention
period (usual care 12%, early rehabilitation 19%, P=0.04).
Compared with those who completed the intervention, those
who withdrew were older (P<0.001), had reduced muscle
strength (P=0.01), and had higher Medical Research Council
dyspnoea scores on admission (P=0.02). See supplementary
table S3 for the reasons participants withdrew.
In the per protocol analysis the risk of hospital admission did
not differ between the groups (hazard ratio 1.1, 95% confidence
interval 0.83 to 1.45, P=0.5, table 2). The total number of days
spent in hospital between the groups were similar (early
rehabilitation 2616 days, usual care 1752, difference 33%,
z=−0.2, P=0.8).
Participants who withdrew within the intervention period were
more likely to die than those who completed the intervention,
with death occurring in 25 of the 61 participants (41%): odds
ratio 3.44 (95% confidence interval 1.91 to 6.19), P<0.001. The
difference in mortality between the two groups did not differ at
any time point in the per protocol analysis.
Post hoc analysis of subgroup with chronic
obstructive pulmonary disease
Three hundred and twenty participants (82%) participants had
a primary diagnosis of chronic obstructive pulmonary disease
(table 1). Overall, 192 (60%) participants in the chronic
obstructive pulmonary disease subgroup were readmitted, with
18 (6%) dying before readmission or the end of the study. Risk
of readmission was similar in both groups (hazard ratio 1.19,
95% confidence interval 0.90 to 1.60, P=0.2). There was no
difference in the primary and secondary outcomes in the chronic
obstructive pulmonary disease subgroup compared with the
whole population.
Exercise performance, quadriceps strength,
and health related quality of life
Significant improvements in functional performance and health
status were observed during the follow-up period in both groups,
with the largest change seen in the first six weeks after the index
admission (fig 5⇓). No statistically significant between group
differences in these measures was observed at 12 months. The
measure for the endurance shuttle walk test was significantly
higher in the early rehabilitation group at six weeks (P=0.03)
but not at other time points during the follow-up period (fig 5).
To account for the functional insult of further admissions to
hospital, an additional reanalysis was conducted in those
participants (n=133) who were not readmitted during the
follow-up period. There was a trend for a difference in functional
performance and health status in the early rehabilitation group
compared with the intention to treat population (fig 6⇓). This
was statistically significant for the endurance shuttle walk test
at six weeks (P=0.02), with a trend at 12 months (P=0.07). No
difference was seen in other functional measures (incremental
shuttle walk test, quadriceps maximal voluntary contraction, St
George’s respiratory questionnaire).
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Uptake of pulmonary rehabilitation after three
months
Participants were offered pulmonary rehabilitation from three
months after recruitment. Uptake in the early rehabilitation
group was significantly reduced (14% v 22%, P=0.04)
Discussion
We report a randomised clinical trial of a tailored early
rehabilitation intervention aimed at enhancing recovery after
unscheduled admission to hospital for acute exacerbation of
chronic respiratory disease. The trial was adequately powered
to determine the effect of the intervention on subsequent
admission to hospital, but the results did not support our
hypothesis that the intervention would reduce the number of
readmissions in the subsequent 12months. In addition, mortality
was increased in the intervention group at 12months. Significant
within group recovery of muscle strength and walking
performance was observed in both groups but, apart from the
endurance shuttle walk test at six weeks, there was no significant
improvement in physical performance in the intervention group
over usual care.
Healthcare utilisation and comparison with
previous studies
The lack of reduction in readmissions in the current study is in
keeping with a smaller scale study from Hong Kong19 but
contrasts with trials of peri-exacerbation pulmonary
rehabilitation, where the rate was reduced over the shorter
term.9 20 21 There are important differences in the population
enrolled and the rehabilitation approach taken in the current
trial, rendering comparison with these previous studies difficult.
We delivered the intervention during the acute phase of the
illness as well as during recovery, with the objective of
preserving physical function and enhancing recovery from the
episode.We did not provide pulmonary rehabilitation as defined
in recent guidelines,22 23 but rather an exercise based intervention
modified to suit the setting of the acute illness. This was by
necessity lower in intensity, although it was provided daily
during the hospital stay using both volitional and non-volitional
training techniques. Supervision in the home recovery phase
was also lighter but supported by a validated self management
programme24 and follow-up telephone support. We recognise,
however, that the relatively short length of hospital stay limited
the number of supervised rehabilitation sessions undertaken and
that the home segment of the intervention was unsupervised.
Participants in the current trial had a greater burden of disease
and comorbidities and had lower muscle strength and exercise
capacity than most reported pulmonary rehabilitation studies.
This higher general level of ill health and frailty in the study
population is in keeping with national and international trends
for patients admitted to hospital with chronic obstructive
pulmonary disease.25 Despite a robust, rigorously applied
treatment algorithm (fig 1), it is likely that the intervention could
not be delivered with sufficient intensity to produce a significant
health benefit. This could have been either because of
insufficient supervision or because the population was too
unwell and frail to undertake progressive exercise in the
circumstances under which they were enrolled.
Safety and mortality
Our finding of increased mortality at the 12 month time point
in the intervention group was unexpected and cannot be
explained directly from our results. We think it is unlikely that
a six week exercise intervention that had no observed health
benefit would directly increase the risk of death at 12 months
and accept that this observation could have occurred by chance.
However, we cannot exclude the possibility that the intervention
resulted in alterations in health behaviour that might have
modified the response to subsequent acute illness later during
the follow-up period, such as delays in seeking medical advice.
In keeping with this, the uptake of outpatient pulmonary
rehabilitation later during the follow-up seems lower in the
intervention group, suggesting that the intervention might have
influenced health behaviour. Indeed it is possible that this
reduced uptake was one of the mediating factors explaining the
lack of reduction in the rate of admission to hospital and the
increased mortality in the intervention group. The time course
of change in health behaviour in response to an intervention is
uncertain, but for conventional pulmonary rehabilitation we
know the reverse is true and that the benefits diminish over the
following 12 months.26
An increased mortality was seen in the intervention group in a
recent trial of a self management intervention27 although as with
the current study, the observation could not be explained from
data obtained within the trial. The observations in the current
trial and that of another trial27are a reminder that interventions
such as self management and rehabilitation cannot be assumed
to be free of risk. We suggest that future trials put data
monitoring and the provision of patient safety in place when
they are designed.
Physical performance and natural recovery
Our approach was informed by data from previous observational
studies in chronic obstructive pulmonary disease, suggesting a
negative short term effect of admission to hospital on muscle
strength,4 limited improvement in walking performance after
discharge,28 and a greater risk of readmission in patients who
remained inactive in the month after discharge.2 However, we
observed significant within group improvements in muscle
strength, field walking performance, and health status in both
groups in the three months after discharge, with limited
additional gains observed in the intervention group. We did
observe a more rapid recovery of endurance walking
performance in the intervention group over usual care at six
weeks, but this difference was not significant by three months.
Some participants may have recovered naturally and achieved
excellent reablement with the assistance of conventional hospital
physiotherapy, which was part of usual care. Conversely, others
in the early rehabilitation group may have not returned to
baseline function because the intervention was insufficiently
intense or they did not adequately adhere to the programme
after discharge.29 Interestingly, the analysis of physical
performance in the subgroup of patients who were not
readmitted, indicated enhanced gains in performance in the
intervention group. This might indicate that benefits from the
intervention are conferred as long as the process is not disrupted
by further unplanned admissions to hospital.
We observed an 18% difference in the total number of bed days
in the intervention group compared with usual care, although
this was not statistically significant, which is in keeping with
trials of pulmonary rehabilitation in stable chronic obstructive
pulmonary disease.26 This could suggest that an exercise
intervention may not influence the number of subsequent
exacerbations but might ameliorate their impact on the patient,
facilitating recovery and earlier discharge. Conversely, the
magnified effect on subsequent hospital bed days in those
patients who completed the intervention may be indicative of
the efficacy of the intervention or identified a group of patients
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2014;349:g4315 doi: 10.1136/bmj.g4315 (Published 8 July 2014) Page 5 of 12
RESEARCH
 o
n
 13 February 2019 by guest. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.g4315 on 8 July 2014. Downloaded from 
in better health who were more able to comply with the
programme and therefore spent fewer days in hospital in the
subsequent year.
Comparison with other strategies after acute
hospital stay
A feature of the intervention in the current trial was the shift
from supervised inpatient therapy to unsupervised home exercise
facilitated by the provision of a self management manual along
with telephone support. Length of hospital stay was five days,
which would be considered standard in the United Kingdom
but relatively short compared with other healthcare systems,
and this limited the opportunity for supervised rehabilitation in
the current trial. In many respects our intervention resembles
elements of post-surgical enhanced recovery programmes or
supported self management programmes rather than
conventional pulmonary rehabilitation. Our results suggest
caution is needed in applying such programmes to recovery
from acute illness, particularly exacerbation of chronic
respiratory disease. A key element of enhanced recovery from
surgery is preoperative preparation, which cannot be included
in an acute illness intervention.We suggest, however, that better
attention to chronic disease management and dovetailing with
conventional stable state and post-exacerbation pulmonary
rehabilitation may have a positive impact on clinical outcomes.
Limitations of this study
We acknowledge some limitations to the interpretation of the
current trial.We enrolled patients with exacerbations of a variety
of chronic respiratory diseases because it is increasingly
accepted that patients with disabling respiratory disease
(including those with different underlying lung diseases such
as interstitial lung disease) benefit from pulmonary rehabilitation
regardless of the nature of the pulmonary pathophysiology.22 23
Most of the participants had chronic obstructive pulmonary
disease, and recruitment from two acute hospitals serving both
urban and rural populations suggests that the participants were
representative of UK clinical practice. Outcomes in the chronic
obstructive pulmonary disease subgroup in the current trial were
indistinguishable from that seen in the whole cohort. We
recognise our conclusions are restricted to patients with fewer
than five admissions in the preceding 12 months. We chose to
exclude this population because admissions of this frequency
are often influenced by physical and psychological comorbidity
or social circumstances or are indicative of the proximity of end
of life30 and as a result would be less modifiable by an exercise
intervention.
Comparison with current guidelines
The recognition of the negative effects of admission to hospital
and the positive outcome of recent trials of post-discharge
pulmonary rehabilitation20 21 has led to recommendations that
pulmonary rehabilitation should be offered to all patients after
discharge,22 although more recently it has been appreciated that
many patients decline the offer of pulmonary rehabilitation
immediately after discharge.31 The current trial was undertaken
before post-discharge pulmonary rehabilitation was considered
“usual care” and therefore conventional post-discharge
pulmonary rehabilitation was not offered to participants,
although they could be enrolled in conventional outpatient
pulmonary rehabilitation after three months if indicated. Our
study therefore substantially extends these previous reports by
testing a modified rehabilitation intervention delivered in a
larger and more representative population in a clinical trial that
was adequately powered to detect a reduction in readmissions
at 12 months.
Conclusions and policy implications
Admission to hospital for acute exacerbations of chronic
respiratory disease is an important event in the clinical course
of disability, which in turn can be ameliorated by pulmonary
rehabilitation. However, the current trial suggests that the acute
admission is not the time to enrol patients in a progressive,
rehabilitation process, which may be beyond the capabilities of
many participants in this situation and moreover might cause
harm.
We have conducted the largest trial to date of an early, tailored
rehabilitation intervention aimed at enhancing recovery and
reducing readmissions to hospital in patients with acute
exacerbations of chronic respiratory disease. The lack of impact
on physical function and readmissions and the observation of
an increased mortality at 12 months in the intervention group
indicate caution before implementing such programmes during
the immediate recovery from acute illness.
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Tables
Table 1| Personal characteristics and baseline measures. Values are numbers (percentages) unless stated otherwise]
Early rehabilitation (n=196)Usual care (n=193)Variables
71.1 (9.4)71.2 (10.0)Mean (SD) age (years)
88 (45)85 (44)Men
26.6 (6.9)26.3 (7.1)Mean (SD) body mass index
4 (3-4)4 (3-4)Median (interquartile range) baseline MRC dyspnoea grade
2 (2-3)2 (1-3)Median (interquartile range) No of comorbidities
1.12 (0.61)1.28 (0.64)Mean (SD) previous FEV1 (L)*
49.5 (16.4)52.9 (18.3)Mean (SD) previous FEV1/FVC (%)*
51.9 (25.1)57.4 (23.6)Previous FEV1 (% predicted)*
46 (30)41 (30)Mean (SD) pack years
Smoking:
43 (22)40 (21)Current
136 (70)137 (71)Former
16 (8)16 (8)Never
73 (37)62 (32)Previous pulmonary rehabilitation
55 (28)50 (26)Home oxygen
Hospital admissions in previous year:
105 (54)100 (52)None
48 (24)53 (27)1
43 (22)40 (21)2-4
Primary diagnosis:
169 (86)151 (78)Chronic obstructive pulmonary disease
11 (6)17 (9)Chronic asthma
8 (4)13 (7)Interstitial lung disease
8 (4)12 (6)Bronchiectasis
12.8 (6.8)13.4 (7.6)Mean (SD) quadriceps strength on admission (kg)
67.7 (34.8-94.0)68.1 (33.9-90.7)Median (interquartile range) St Georges respiratory questionnaire total on admission
92.7 (14.7)90.4 (15.0)Mean (SD) heart rate on admission (bpm)
7 (4)9 (5)Required non-invasive ventilation on admission
MRC=Medical Research Council; FEV1=forced expiratory volume in one second; FVC=forced vital capacity.
*Available in 267 participants (usual care n=136, early rehabilitation n=131).
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Table 2| Healthcare utilisation. Comparison of number of hospital admissions per patient and hospital days per patient in 12 months after
admission. Values are means (standard deviations) unless stated otherwise
Adjusted for covariates†Adjusted for site only*
Early
rehabilitationUsual careVariables P value
Incidence rate ratio (95%
CI)P value
Incidence rate ratio (95%
CI)
No of hospital admissions
Intention to treat:
0.90.98 (0.74 to 1.30)0.91.02 (0.76 to 1.35)1.48 (1.89).1.60 (2.29)Total
1.00.99 (0.72 to 1.37)0.91.02 (0.73 to 1.41)1.10 (1.64)1.20 (1.94)Respiratory
0.71.09 (0.71 to 1.70)0.91.04 (0.66 to 1.64)0.39 (0.81)0.39 (0.90)Non-respiratory
Per protocol:
0.50.91 (0.67 to 1.22)0.60.92 (0.68 to 1.26)1.49 (1.87)1.67 (2.39)Total
0.70.94 (0.67 to 1.33)0.80.95 (0.67 to 1.34)1.14 (1.65)1.28 (2.02)Respiratory
0.90.95 (0.58 to 1.56)0.60.87 (0.52 to 1.45)0.35 (0.75)0.39 (0.92)Non-respiratory
No of hospital days
Intention to treat:
0.60.88 (0.58 to 1.34)0.80.95 (0.63 to 1.44)12.0 (18.0)14.8 (27.7)Total
0.80.93 (0.56 to 1.53)0.90.97 (0.60 to 1.59)9.1 (18.5)11.2 (23.1)Respiratory
0.71.17 (0.55 to 2.46)0.61.24 (0.57 to 2.68)3.5 (9.3)3.6 (12.0)Non-respiratory
Per protocol:
0.20.75 (0.48 to 1.19)0.40.81 (0.52 to 1.28)11.1 (16.2)15.4 (28.7)Total
0.40.80 (0.47 to 1.38)0.50.83 (0.49 to 1.41)8.2 (13.7)11.9 (24.0)Respiratory
0.71.16 (0.50 to 2.73)0.90.95 (0.39 to 2.28)2.9 (8.0)3.5 (12.0)Non-respiratory
Table shows both intention to treat and per protocol analyses, defined as participants who remained within the study during the six week intervention period.
Analyses are shown both unadjusted and adjusted for covariates. Incident rate ratio is relative to the usual care group and offset for time exposed (time to death).
*Adjusted for site only.
†Adjusted for site, age, diagnosis, previous hospital admissions, quadriceps strength at baseline, Medical Research Council dyspnoea grade, and number of
comorbidities.
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Figures
Fig 1 Training intervention algorithm. Prescription protocol for progressive aerobic, resistance, and non-volitional training
Fig 2 Flow of participants through study
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Fig 3 Cumulative incidence of hospital readmission, using competing risks regression analysis, in usual care and early
rehabilitation groups. The groups did not differ (P=0.4)
Fig 4 Kaplan-Meier plots showing survival in follow-up period
Fig 5 Intention to treat analysis: change in functional measures (from first measure) in year after admission in all participants.
Initial measures were taken at discharge for incremental and endurance shuttle walk tests and at baseline for quadriceps
maximal voluntary contraction and St George’s respiratory questionnaire. *P<0.05
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Fig 6 Change in functional measures (from first measure) in year after admission in participants who were not readmitted
in subsequent year (n=156) Initial measures were taken at discharge for incremental and endurance shuttle walk tests and
at baseline for maximal voluntary contraction and St George’s respiratory questionnaire. *P<0.05
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